N. ÖZER, "Clinical studies conducted with new oral anticoagulants in atrial fibrillation: Which oral anticoagulant can be considered for which case in light of the clinical studies?," TURK KARDIYOLOJI DERNEGI ARSIVI-ARCHIVES OF THE TURKISH SOCIETY OF CARDIOLOGY , vol.44, pp.33-40, 2016
ÖZER, N. 2016. Clinical studies conducted with new oral anticoagulants in atrial fibrillation: Which oral anticoagulant can be considered for which case in light of the clinical studies?. TURK KARDIYOLOJI DERNEGI ARSIVI-ARCHIVES OF THE TURKISH SOCIETY OF CARDIOLOGY , vol.44 , 33-40.
ÖZER, N., (2016). Clinical studies conducted with new oral anticoagulants in atrial fibrillation: Which oral anticoagulant can be considered for which case in light of the clinical studies?. TURK KARDIYOLOJI DERNEGI ARSIVI-ARCHIVES OF THE TURKISH SOCIETY OF CARDIOLOGY , vol.44, 33-40.
ÖZER, NECLA. "Clinical studies conducted with new oral anticoagulants in atrial fibrillation: Which oral anticoagulant can be considered for which case in light of the clinical studies?," TURK KARDIYOLOJI DERNEGI ARSIVI-ARCHIVES OF THE TURKISH SOCIETY OF CARDIOLOGY , vol.44, 33-40, 2016
ÖZER, NECLA. "Clinical studies conducted with new oral anticoagulants in atrial fibrillation: Which oral anticoagulant can be considered for which case in light of the clinical studies?." TURK KARDIYOLOJI DERNEGI ARSIVI-ARCHIVES OF THE TURKISH SOCIETY OF CARDIOLOGY , vol.44, pp.33-40, 2016
ÖZER, N. (2016) . "Clinical studies conducted with new oral anticoagulants in atrial fibrillation: Which oral anticoagulant can be considered for which case in light of the clinical studies?." TURK KARDIYOLOJI DERNEGI ARSIVI-ARCHIVES OF THE TURKISH SOCIETY OF CARDIOLOGY , vol.44, pp.33-40.
@article{article, author={NECLA ÖZER}, title={Clinical studies conducted with new oral anticoagulants in atrial fibrillation: Which oral anticoagulant can be considered for which case in light of the clinical studies?}, journal={TURK KARDIYOLOJI DERNEGI ARSIVI-ARCHIVES OF THE TURKISH SOCIETY OF CARDIOLOGY}, year=2016, pages={33-40} }